Hepatocellular carcinoma: could antiplatelet drugs be used to prevent HBV-associated hepatocellular carcinoma?
Claire
C
Greenhill
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control* / Q000821:virology*; D018890:Chemoprevention; D000077144:Clopidogrel; D004195:Disease Models, Animal; D018450:Disease Progression; D019694:Hepatitis B, Chronic / Q000150:complications*; D006801:Humans; D008113:Liver Neoplasms / Q000517:prevention & control* / Q000821:virology*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine